Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Holm Uhlig


Holm Uhlig

Professor of Paediatric Gastroenterology

  • Director Centre for Human Genetics

The gastrointestinal immune system has evolved to counteract the invasion of pathogens. To allow a strong inflammatory immune response during infection but avoid tissue damage there is a need for effective immune regulation. Defects in immune regulation lead to immunopathology such as inflammatory bowel disease or environmental enteropathy or celiac disease.

About one-fifth of all patients with inflammatory bowel disease present with initial symptoms during childhood and adolescents. In particular in the very young children patients, an underlying immunodeficiency may cause Iinflammatory bowel disease-like symptoms. The analysis of immune deviation in children with inflammatory bowel disease does contribute to the understanding of the complex puzzle of molecular mechanisms involved in IBD.


Recent publications

HLA-DRB1*01:03 in patients with inflammatory bowel disease: a genotype-phenotype association study.

Journal article

Zhang Q. et al, (2026), The lancet. Gastroenterology & hepatology

Interleukin-10 Autoantibodies and HLA-DRB1*01:03 in Inflammatory Bowel Disease.

Journal article

Gharahdaghi N. et al, (2026), The New England journal of medicine, 394, 2212 - 2222

Targeting SYK to alleviate MDSC-driven immunosuppression and augment anti-PD1 efficacy.

Journal article

Zeng Z. et al, (2026), Science China. Life sciences